Filing metadata

Accession number
0001209191-23-057407
Form type
Form 4
Filer
Stoke Therapeutics, Inc.
CIK
CIK 1623526
Filed
Dec 05, 2023
Reporting period
Dec 01, 2023
Description
Insider transaction

Explore SEC Filings Hub